Azienda Ospedaliera Carlo Poma
In research, Azienda Ospedaliera Carlo Poma stands highest in Health Sciences (#4,357 of 11,982 worldwide) and Medicine (#5,089 of 10,443 worldwide), 2022–2025.
- World rank, 2022–2025
- #13,717 of 28,054 · #16,959 all time
- Rank in Italy
- #396 of 618
- Research works
- 699 ▼ 14% vs 2013–17
- Citations
- 14k 19.8 per fractional work
- Top-10% rate
- 19.4% record average 16.5%
- Open access
- 40% world 28%
What is Azienda Ospedaliera Carlo Poma known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #4,357 of 11,982 | 19.2% | 95 | #4902 | |
| MedicineField | #5,089 of 10,443 | 18.5% | 90 | #4483 |
Each strip is that field’s whole ranked pool, with the notch where Azienda Ospedaliera Carlo Poma sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.
- Medicine 4.2×
- Dentistry 2.1×
- Nursing 1.8×
- Immunology and Microbiology 1.5×
- Health Professions 1.1×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Neuroscience 0.6×
- Psychology 0.5×
- Mathematics 0.4×
- Business, Management and Accounting 0.3×
- Environmental Science 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Decision Sciences 0.2×
- Agricultural and Biological Sciences 0.2×
- Materials Science 0.1×
- Engineering 0.1×
- Arts and Humanities 0.1×
- Social Sciences 0.1×
- Economics, Econometrics and Finance 0.1×
- Chemistry 0.0×
Who are the top researchers at Azienda Ospedaliera Carlo Poma?
Ranked on the composite score, Massimo Franchini, Giuseppe Capovilla and Enrico Aitini lead among researchers whose main affiliation is Azienda Ospedaliera Carlo Poma.
- 1 Massimo Franchini Italy · #121,887 worldwide 334 citations · 83 works
- 2 Giuseppe Capovilla Italy · #291,146 worldwide 90 citations · 23 works
- 3 Enrico Aitini Italy · #334,039 worldwide 95 citations · 30 works
- 4 Francesco Frattini Italy · #517,772 worldwide 52 citations · 21 works
- 5 Alfonso Ciccone Italy · #517,972 worldwide 69 citations · 36 works
- 6 Attilio Carlo Salgarelli Italy · #808,395 worldwide 3 citations · 28 works
- 7 Mioli Italy · #1,026,539 worldwide 3 citations · 21 works
- 8 P. Parma Italy · #1,367,588 worldwide 1 citations · 15 works
Which keywords describe research at Azienda Ospedaliera Carlo Poma?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, SARS-CoV-2, Pandemic, ACE2 Receptor, Thrombosis, Immune Response, Pathophysiology and Inflammation.
- von Willebrand Disease
- Immune Thrombocytopenic Purpura
- Post-acute COVID-19 Syndrome
- Neurologic Manifestations
- Pregnancy
- Cognitive Impairment
- Thrombus Formation
- Hemophilia
- Hemostasis
- Clinical Trials
- Prophylaxis
- spike protein
- Immunity
- Mutation
- Vaccine
- Antiviral Treatment
- Pathophysiology
- Inflammation
- ACE2 Receptor
- SARS-CoV-2
- Epidemiology
- Pandemic
- Thrombosis
- Immune Response
- Clinical Characteristics
- Cytokine Storm
- Viral Transmission
- Treatment
- Coronavirus
- Diagnosis
- Management
- Risk Factors
- Factor VIII
- Recombinant Factor VIIa
- Guidelines
- Heart Failure
- Prenatal Diagnosis
- Neuropathology
- Rehabilitation
- Platelets
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology19▲ 4.3×68 topics
- SARS-CoV-213▲ 35×5 topics
- Pandemic12▲ 10×5 topics
- ACE2 Receptor11▲ 41×2 topics
- Thrombosis10▲ 33×6 topics
- Inflammation9▲ 4.0×35 topics
- Immune Response8▲ 12×10 topics
- Pathophysiology7▲ 21×6 topics
- Clinical Characteristics6▲ 44×2 topics
- Antiviral Treatment6▲ 52×1 topic
- Cytokine Storm6▲ 52×1 topic
- Vaccine6▲ 13×8 topics
- Viral Transmission6▲ 33×3 topics
- Mutation5▲ 25×2 topics
- Treatment5▲ 3.9×26 topics
- Immunity5▲ 11×4 topics
- Coronavirus5▲ 21×1 topic
- spike protein5▲ 42×1 topic
- Diagnosis4▲ 4.2×19 topics
- Prophylaxis4▲ 28×4 topics
- Management4▲ 4.6×17 topics
- Clinical Trials4▲ 5.0×12 topics
- Risk Factors4▲ 3.0×16 topics
- Hemostasis3▲ 31×4 topics
- Factor VIII3▲ 192×1 topic
- Hemophilia3▲ 192×1 topic
- Recombinant Factor VIIa3▲ 62×2 topics
- Thrombus Formation3▲ 38×3 topics
- Guidelines3▲ 5.3×9 topics
- Cognitive Impairment3▲ 9.5×5 topics
- Heart Failure3▲ 5.3×8 topics
- Pregnancy2▲ 11×6 topics
- Prenatal Diagnosis2▲ 15×5 topics
- Neurologic Manifestations2▲ 28×1 topic
- Neuropathology2▲ 17×2 topics
- Post-acute COVID-19 Syndrome2▲ 28×1 topic
- Rehabilitation2▲ 5.5×9 topics
- Immune Thrombocytopenic Purpura2▲ 78×1 topic
- Platelets2▲ 30×2 topics
- von Willebrand Disease2▲ 78×1 topic
Which research topics does Azienda Ospedaliera Carlo Poma publish most on?
By volume in 2022–2025: COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Hemophilia Treatment and Research and Long-Term Effects of COVID-19.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 COVID-19 Clinical Research Studies Infectious Diseases 6 works
- 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 5 works
- 3 Hemophilia Treatment and Research Hematology 3 works
- 4 Long-Term Effects of COVID-19 Neurology 2 works
- 5 Platelet Disorders and Treatments Hematology 2 works
- 6 Lipoproteins and Cardiovascular Health Surgery 2 works
- 7 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 1 works
- 8 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
- 9 COVID-19 Impact on Reproduction Obstetrics and Gynecology 1 works
- 10 Uterine Myomas and Treatments Obstetrics and Gynecology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Azienda Ospedaliera Carlo Poma's research output changed?
Output in 2018–2022 was 14% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mantova
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.